In this episode, experts discuss the latest advancements in the multimodal treatment of undifferentiated pleomorphic sarcoma of the extremities.
Back
Moving the Needle in Undifferentiated Pleomorphic Sarcoma
In this series of OncChats: Moving the Needle in Undifferentiated Pleomorphic Sarcoma, experts discuss the multidisciplinary advances in treating undifferentiated pleomorphic sarcoma of the extremities, highlighting the benefits of combining pembrolizumab with radiation and surgery to improve disease-free survival.
Moving the Needle in Undifferentiated Pleomorphic Sarcoma
Episodes
All
All
In this episode, experts discuss the rationale behind the combined treatment in the Stand Up to Cancer SARC 032 trial.
In this episode, experts discuss the potential of radiation therapy to enhance immune response in soft tissue sarcomas.
In this episode, experts shed light on the surgical approach to soft tissue sarcomas.
In this episode, experts discuss the impact of neoadjuvant radiation and immunotherapy on surgical planning in patients with soft tissue sarcomas.
In this episode, experts discuss the landmark SARC 032 study, highlighting the importance of multidisciplinary collaboration.
In this episode, experts highlight the key takeaways from the Stand Up to Cancer SARC 032 study and its clinical implications.
Advertisement
Advertisement
Trending on OncLive
1
Dr Banerjee on the FDA Approval of Iberdomide Plus Daratumumab/Dexamethasone in R/R Myeloma
2
FDA Grants Fast Track Designation to Spevatamig in Advanced and Metastatic Biliary Tract Carcinoma
3
Longer-Term Data Continue to Support Earlier Integration of CAR T-Cell Therapy in R/R Myeloma
4
Trastuzumab Rezetecan Elicits High ORR in HER2-High and HER2-Low Salivary Gland Carcinoma
5